UBS (Lux) Digital Health Equity Fund UBH EUR

Reference Data

ISIN LU1683288770
Valor Number 38312207
Bloomberg Global ID
Fund Name UBS (Lux) Digital Health Equity Fund UBH EUR
Fund Provider UBS Asset Management (Europe) S.A. 33A avenue J.-F. Kennedy
2010 Luxembourg
Web: https://www.ubs.com/lu/en.html
Phone: +352-27151
Fund Provider UBS Asset Management (Europe) S.A.
Representative in Switzerland UBS Fund Management (Switzerland) AG
Basel
Phone: +41 61 288 49 10
Distributor(s) UBS AG
Basel
Phone: +41 61 288 75 01
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel)
Redemption Condition The fund management company and/or distributor charges a redemption commission (different commissions can be charged for the same fund depending on the sales channel)
Investment Strategy *** The objective of the Subfund is to achieve the highest possible return in US dollars (Reference Currency), while taking due account of the principle of risk diversification, the security of the capital invested, and the liquidity of the assets. This Subfund aims to outperform the return of the MSCI World ESG Leaders (NR) benchmark. The Subfund is actively managed. The benchmark is used as a reference point for portfolio construction and as a basis for setting risk constraints, and/or for Performance Fee measurement purposes. The majority of the Subfund’s equity securities will not necessarily be components of or have weightings derived from the benchmark. The Investment Manager will use its discretion to significantly deviate the weighting of certain components of the benchmark and to significantly invest in companies or sectors not included in the benchmark in order to take advantage of specific investment opportunities.
Peculiarities

Fund Prices

Current Price * 105.52 EUR 10.03.2025
Previous Price * 109.67 EUR 07.03.2025
52 Week High * 123.04 EUR 19.02.2025
52 Week Low * 105.48 EUR 19.04.2024
NAV * 105.52 EUR 10.03.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 811,652,750
Unit/Share Assets *** 8,290,055
Trading Information SIX

Performance

YTD Performance -4.19% 31.12.2024
10.03.2025
YTD Performance (in CHF) -2.71% 31.12.2024
10.03.2025
1 month -11.18% 10.02.2025
10.03.2025
3 months -12.31% 10.12.2024
10.03.2025
6 months -7.71% 10.09.2024
10.03.2025
1 year -12.91% 11.03.2024
10.03.2025
2 years -6.31% 10.03.2023
10.03.2025
3 years -22.09% 10.03.2022
10.03.2025
5 years -12.69% 10.03.2020
10.03.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

TransMedics Group Inc 4.75%
Zai Lab Ltd Ordinary Shares 4.58%
Inspire Medical Systems Inc 4.40%
Redcare Pharmacy NV 4.32%
Veeva Systems Inc Class A 4.25%
Zealand Pharma AS 4.22%
Natera Inc 4.06%
Krystal Biotech Inc 3.65%
JD Health International Inc 3.63%
Exact Sciences Corp 3.54%
Last data update 28.02.2025

Cost / Risk

TER 1.23%
TER date 31.05.2024
Performance Fee ***
PTR
Max. Management Fee *** 1.50%
Ongoing Charges *** 1.23%
SRRI ***
SRRI date *** 28.02.2025

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)